[1]李婷婷.沙格列汀对早期2型糖尿病患者胰腺功能的改善作用[J].中国实用乡村医生杂志,2020,27(06):44-46.[doi:10.3969/j.issn.1672-7185.2020.06.014 ]
 LI Tingting.The Improvement of Pancreatic Function in Patients with Early Type 2 Diabetes Mellitus[J].Chinese Practical Journal of Rural Doctor,2020,27(06):44-46.[doi:10.3969/j.issn.1672-7185.2020.06.014 ]
点击复制

沙格列汀对早期2型糖尿病患者胰腺功能的改善作用()
分享到:

《中国实用乡村医生杂志》[ISSN:1672-7185/CN:21-1502/R]

卷:
27
期数:
2020年06期
页码:
44-46
栏目:
论著
出版日期:
2020-06-15

文章信息/Info

Title:
The Improvement of Pancreatic Function in Patients with Early Type 2 Diabetes Mellitus
文章编号:
 1672-7185(2020)06-0044-03 
作者:
李婷婷
作者单位:124000 辽宁 盘锦,盘锦辽油宝石花医院急诊科
Author(s):
LI Tingting
(Emergency Department, Liaoyoubaoshihua Hospital, Panjin 124000, Liaoning Province, China)
关键词:
 糖尿病2型沙格列汀胰岛素胰腺内分泌
Keywords:
 Diabetes Mellitus Type 2 Sagletin Insulin Pancreas Endocrine
分类号:
 R587.1 
DOI:
10.3969/j.issn.1672-7185.2020.06.014
文献标志码:
 A
摘要:
 目的 探讨沙格列汀对早期2型糖尿病( T2D M)患者胰腺功能的改善作用。方法 收集2019年1—12月盘锦辽油宝石花医院收治的T2DM患者110例,随机分为对照组和观察组各55例。对照组采用胰岛素泵强化治疗,观察组在其基础上加用沙格列汀治疗,比较两组治疗后血糖、胰腺分泌和胰岛素抵抗改善情况。结果 两组经治疗后,T2时间点C肽( C P)和 β细胞功能指数、胰岛素抵抗指数组间差异均有统计学意义(P<0.05)。结论 沙格列汀能够提高早期T2DM患者第二时相胰岛素分泌能力,并且进一步缓解胰岛素抵抗状态。
Abstract:
 Objective To investigate the effect of sagletin in the improvement of pancreatic function in patients with early type 2 diabetes mellitus (T2DM) by. Methods A total of 110 T2DM patients admitted to our hospital from January to December 2019 were randomly divided into control group and observation group with 55 cases each. The control group was treated with intensive insulin pump, and the observation group was treated with saggliptin on the basis of it. The improvement of blood glucose, pancreatic secretion and insulin resistance were compared between the two groups after treatment. Results After treatment, there were significant differences in CP level, beta cell function index and insulin resistant indices at T2 time point between the two groups (P<0.05). Conclusion Sagletin can improve the second phase insulin secretion in early T2DM patients, and further alleviate the state of insulin resistance.

参考文献/References:

[1] 徐燕.糖尿病前期及糖尿病流行病学与危险因素调查分析[J].中国医学创新,2019,16(28):107-110.
[2] 黄倩,陈科艳,余昉,等.评价沙格列汀与格列美脲对T2DM患者B MI及低血糖发生率的影响[ J].西南国防医药,2019,29(11):1116-1120.
[3] 郑超君,徐锦龙,马卫成.沙格列汀联合门冬胰岛素30治疗老年Ⅱ型糖尿病患者的系统评价[ J].循证医学,2019,19(4):229-236.
[4] 中华医学会糖尿病学分会,国家基层糖尿病防治管理办公室.国家基层糖尿病防治管理指南(2018)[J].中华内科杂志,2018,57(12):885-893.
[5] 陈晓,周典,曾靓.沙格列汀与磺脲类药物联合二甲双胍药物经济性评价的M e ta分析[ J].国际医药卫生导报,2019,25(21):3507-3512.
[6] 闫玲,宋康佳,胡艳粉,等.对2型糖尿病胰岛素泵强化治疗效果分析[ J ].糖尿病新世界,2019,22(21): 129­-130.
[7]徐建宾,菅小红,申晶,等.沙格列汀片联合胰岛素强化治疗2型糖尿病血糖不达标患者的临床研究[ J].中国临床药理学杂志,2019,35(19):2239-2242.
[8] 王宏涛,陈培红,丁花花.沙格列汀联合胰岛素泵短期强化降血糖治疗对2型糖尿病患者β细胞分泌功能及胰岛素抵抗的影响[ J].药物评价研究,2019,42(11):2226-2229.
[9] 钟钻仪,侯淑芳.短期胰岛素泵治疗对不同病程2型糖尿病患者胰岛 β细胞功能的影响[ J ].实用临床医学,2011,12(6):25-26,32.
[10] 蒲梦如,刘建辉.Nrf2信号通路与胰腺β细胞功能障碍[J].中国现代应用药学,2019,36(8):1001-1006.
[11] 刘春燕,白宁,张晓乐,等.DPP-4抑制剂西格列汀对2型糖尿病合并肥胖患者血清vaspin水平影响研究[J].检验医学与临床,2017,14(8):1101-1106,1110.

相似文献/References:

[1]赵峰英 黄晓婷 王燕.品管圈对糖尿病患者胰岛素注射部位皮下脂肪增生相关知识知晓率的影响研究[J].中国实用乡村医生杂志,2018,25(11):50.[doi:10.3969/j.issn.1672-7185.2018.11.020 ]
 ZHAO Fengying,HUANG Xiaoting,WANG Yan.Effect of Quality Control Circle on Knowledge Awareness Rate of Subcutaneous Fat Hyperplasia at Insulin Injection Site in Diabetic Patients[J].Chinese Practical Journal of Rural Doctor,2018,25(06):50.[doi:10.3969/j.issn.1672-7185.2018.11.020 ]
[2]王维清.糖尿病延续性护理的研究进展[J].中国实用乡村医生杂志,2018,25(05):34.[doi:10.3969/j.issn.1672-7185.2018.05.015 ]
[3]贺薇.男性2型糖尿病患者并发良性甲状腺结节的激素水平特征分析[J].中国实用乡村医生杂志,2019,26(10):42.[doi:10.3969/j.issn.1672-7185.2019.10.016 ]
 HE Wei.Hormone Level Characteristics of Male Type 2 Diabetes Mellitus Complicated with Benign Thyroid Nodules[J].Chinese Practical Journal of Rural Doctor,2019,26(06):42.[doi:10.3969/j.issn.1672-7185.2019.10.016 ]
[4]胡晓娜.糖尿病患者心脏自主神经病变特点分析[J].中国实用乡村医生杂志,2019,26(10):45.[doi:10.3969/j.issn.1672-7185.2019.10.017 ]
 HU Xiaona.Characteristic Analysis of Cardiac Autonomic Neuropathy in Diabetic Patients[J].Chinese Practical Journal of Rural Doctor,2019,26(06):45.[doi:10.3969/j.issn.1672-7185.2019.10.017 ]
[5]周素焕.综合护理对糖尿病低血糖患者的护理效果研究[J].中国实用乡村医生杂志,2020,27(02):42.[doi:10.3969/j.issn.1672-7185.2020.02.016 ]
 ZHOU Suhuan.Effect of Comprehensive Nursing on Diabetes Mellitus Patients with Hypoglycemia[J].Chinese Practical Journal of Rural Doctor,2020,27(06):42.[doi:10.3969/j.issn.1672-7185.2020.02.016 ]
[6]汪浩.达格列净对2型糖尿病伴代谢综合征患者血糖 血压和血脂的调节作用[J].中国实用乡村医生杂志,2020,27(06):41.[doi:10.3969/j.issn.1672-7185.2020.06.013 ]
 WANG Hao.The Regulatory Effect of Dagglitazine on Blood Glucose, Blood Pressure and Blood Lipid in Patients with Type 2 Diabetes Mellitus Combined with Metabolic Syndrome[J].Chinese Practical Journal of Rural Doctor,2020,27(06):41.[doi:10.3969/j.issn.1672-7185.2020.06.013 ]
[7]范晓东.利拉鲁肽联合二甲双胍治疗2型糖尿病临床疗效观察[J].中国实用乡村医生杂志,2018,25(06):44.[doi:10.3969/j.issn.1672-7185.2016.06.018 ]
 FAN Xiaodong.The Clinical Efficacy of Liraglutide Combined with Metformin in Treatment of Type 2 Diabetes Mellitus[J].Chinese Practical Journal of Rural Doctor,2018,25(06):44.[doi:10.3969/j.issn.1672-7185.2016.06.018 ]
[8]金菊.利格列汀治疗新诊断2型糖尿病的随机对照研究[J].中国实用乡村医生杂志,2018,25(02):40.[doi:10.3969/j.issn.1672-7185.2018.02.021 ]
 JINJu.A Randomized Case-control Study of Trajenta for Newly Diagnosed Type 2 Diabetes Mellitus[J].Chinese Practical Journal of Rural Doctor,2018,25(06):40.[doi:10.3969/j.issn.1672-7185.2018.02.021 ]

备注/Memo

备注/Memo:
收稿日期:2020-03-03)

更新日期/Last Update: 2020-07-08